APA (7th ed.) Citation

Maha A. Behairy, Osama Mahmoud, Ayman Rabie Ibrahim, & Aber H. Baki. (2022). Comparison between paricalcitol versus cinacalcet therapy in the management of secondary hyperparathyroidism among prevalent hemodialysis patients. Society of Diabetic Nephropathy Prevention.

Chicago Style (17th ed.) Citation

Maha A. Behairy, Osama Mahmoud, Ayman Rabie Ibrahim, and Aber H. Baki. Comparison Between Paricalcitol Versus Cinacalcet Therapy in the Management of Secondary Hyperparathyroidism Among Prevalent Hemodialysis Patients. Society of Diabetic Nephropathy Prevention, 2022.

MLA (9th ed.) Citation

Maha A. Behairy, et al. Comparison Between Paricalcitol Versus Cinacalcet Therapy in the Management of Secondary Hyperparathyroidism Among Prevalent Hemodialysis Patients. Society of Diabetic Nephropathy Prevention, 2022.